Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
Aliment Pharmacol Ther. 2021 Dec;54(11-12):1463-1471. doi: 10.1111/apt.16638. Epub 2021 Oct 12.
The rising incidence of early onset colorectal cancer (EOCRC) might reflect a novel tumour entity.
To evaluate clinicopathological characteristics of sporadic EOCRC (in patients < 50 years old) and investigate changes over time METHODS: All patients with sporadic EOCRC between 1989 and 2016 were included and divided by age: 20-29 years (group I), 30-39 years (group II) and 40-49 years (group III).
We included 6400 patients. The presence of signet-ring cells and more poorly differentiated tumours were more common in the younger age groups: 5.4% and 3.7% for signet-ring cells in group I and II vs 1.4% in group III (P < 0.01), and 28.5% and 20.3% for poorly differentiated in group I and II vs 16.6% in group III, (P < 0.01 group I; P = 0.07 group II). Positive lymph nodes were more frequently observed in the younger age groups: 16.2% in group I vs 9.3% in group II (P = 0.01) and 7.9% (P < 0.01) in group III. Over time, a greater proportion of CRCs were diagnosed in women in group I (34.5% < 2004 vs 54.9%>2005, P = 0.09), and a higher percentage of rectal cancer was found in age group III (34.3% < 2004 vs 40.7% > 2005, P < 0.01). Mean overall survival was 6.3 years and improved over time.
EOCRC is not only characterised by age of onset but also by the more frequent presence of signet-ring cells, more poorly differentiated tumours, and higher risk of lymph node metastases. In the most recent years, a higher proportion of rectal cancer was found from the age of 30 years, and a higher proportion of CRCs were diagnosed in females below the age of 30 years.
早发性结直肠癌(EOCRC)的发病率不断上升,可能反映出一种新型肿瘤实体。
评估散发性 EOCRC(发病年龄<50 岁)的临床病理特征,并研究其随时间的变化。
纳入 1989 年至 2016 年间所有散发性 EOCRC 患者,并根据年龄分为三组:20-29 岁(I 组)、30-39 岁(II 组)和 40-49 岁(III 组)。
共纳入 6400 例患者。在年龄较小的组中,存在印戒细胞和分化程度较低的肿瘤更为常见:I 组和 II 组的印戒细胞为 5.4%和 3.7%,而 III 组为 1.4%(P<0.01);I 组和 II 组分化程度较低的肿瘤为 28.5%和 20.3%,而 III 组为 16.6%(P<0.01 组 I;P=0.07 组 II)。在年龄较小的组中,阳性淋巴结更为常见:I 组为 16.2%,而 II 组为 9.3%(P=0.01),III 组为 7.9%(P<0.01)。随着时间的推移,I 组中更多的 CRC 被诊断为女性(34.5%<2004 年 vs 54.9%>2005 年,P=0.09),而 III 组中更多的直肠癌病例被发现(34.3%<2004 年 vs 40.7%>2005 年,P<0.01)。总体中位生存时间为 6.3 年,且随时间推移而改善。
EOCRC 不仅表现为发病年龄早,还表现为更常见的印戒细胞、分化程度较低的肿瘤和更高的淋巴结转移风险。在最近几年,30 岁以上患者中直肠癌的比例更高,30 岁以下女性中 CRC 的比例更高。